• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 66 of 100
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
HealthValeant Is Being Sued Over the ‘Female Viagra’ Pill
By Reuters and Tekendra ParmarNovember 2, 2016
Fortune Brainstorm Health 2016
FinanceWhy Express Scripts CMO Thinks Drug Price Regulation Is a “Bad Idea”
By Jen WiecznerNovember 2, 2016
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
HealthHow Drug Development Cycles May Be ‘Getting Smaller and Smaller’
By Kia KokalitchevaNovember 2, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
FinanceHere’s Why Valeant Selling Salix Was a Huge Surprise to the Stock Market
By Jen WiecznerNovember 1, 2016
Key Speakers At The Bloomberg Year Ahead 2015 Conference
HealthMylan’s EpiPen Price Hikes Reportedly Add Millions to Pentagon Costs
By Reuters and Michelle TohOctober 28, 2016
Bayer Buys Monsanto
FinanceBayer Beats Expectations with a Payoff in Profits
By Reuters and Michelle TohOctober 26, 2016
Most Powerful Women 2015
HealthThis Could Be the Next Blockbuster Drug for GlaxoSmithKline
By ReutersOctober 24, 2016
Sanders Joins Clinton At Campaign Event In Portsmouth
HealthBernie Sanders Butts Heads with Cancer Drug Maker over a Huge Price Hike
By Sy MukherjeeOctober 21, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthWhy These Copycat Drugs Aren’t Slashing Best-Sellers’ Prices
By Sy MukherjeeOctober 18, 2016
How Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes
HealthHow Valeant Is Justifying Its New Kinder, Gentler Drug Price Hikes
By Sy MukherjeeOctober 17, 2016
Mother sleeping with newborn baby on bed
HealthHomeopathic Treatments May Have Led to Deaths in Teething Babies
By Sy MukherjeeOctober 12, 2016
Novo Nordisk Chief Executive Officer Lars Soerensen Interview
LeadershipThis Big Pharma Chief Was Just Named the World’s ‘Best-Performing’ CEO—Again
By Sy MukherjeeOctober 12, 2016
Cancer Consulting Elderly Person
HealthWhy Pharma Giant Bristol-Myers Squibb’s Shares Took a Big Hit Today
By Sy MukherjeeOctober 10, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
HealthThe FDA’s Most Controversial Drug Approval of the Year Just Hit a Huge Snag
By Sy MukherjeeOctober 7, 2016
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
HealthAlnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
By Sy MukherjeeOctober 6, 2016
1...
  • 64
  • 65
  • 66
  • 67
  • 68
...100
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethicplaceholder alt text
By Orianna Rosa RoyleJune 24, 2026
Success
Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurantsplaceholder alt text
By Orianna Rosa RoyleJune 25, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.